Board of Directors
Dr. Juncai (Chris) Bai
Board Member
Dr. Juncai (Chris) Bai joins the BioFutureRx Board of Directors with deep expertise in peptide drug development and commercial-scale manufacturing. He is the Founder, Chairman of the Board, and Chief Executive Officer of Ambio, where he also oversees AmbioPharm's operations across the United States and China.
Earlier in his career, Dr. Bai served as President and Chief Executive Officer of American Peptide Company, where he built the company's cGMP manufacturing business. He led peptide process development, scale-up, and cGMP manufacturing standards — including the solution-phase process development and manufacture of a 22-amino-acid peptide at 40-kilogram scale.
That rare combination of scientific depth and large-scale manufacturing experience — particularly in peptides — brings valuable perspective to BioFutureRx's board as the company advances its proprietary peptide program.
Areas of focus
- Peptide drug development
- cGMP manufacturing & scale-up
- Global biopharma leadership
